Cargando…

Symptom burden and splenomegaly in patients with myelofibrosis in the United States: a retrospective medical record review

Myelofibrosis (MF) is a clonal hematopoietic malignancy characterized by constitutional and localized symptoms, progressive splenomegaly, bone marrow fibrosis, and cytopenias. Although MF is well studied, few studies exist regarding its symptomatic burden in routine clinical practice. This study aim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mitra, Debanjali, Kaye, James A, Piecoro, Lance T, Brown, Jennifer, Reith, Kelly, Mughal, Tariq I, Sarlis, Nicholas J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2013
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3892393/ https://www.ncbi.nlm.nih.gov/pubmed/24403262 http://dx.doi.org/10.1002/cam4.136

Ejemplares similares

Myelofibrosis-associated complications: pathogenesis, clinical manifestations, and effects on outcomes
por: Mughal, Tariq I, et al.
Publicado: (2014)

How I treat splenomegaly in myelofibrosis
por: Cervantes, F
Publicado: (2011)

Understanding Splenomegaly in Myelofibrosis: Association with Molecular Pathogenesis
por: Song, Moo-Kon, et al.
Publicado: (2018)

Captopril mitigates splenomegaly and myelofibrosis in the Gata1 (low) murine model of myelofibrosis
por: Corey, Seth J., et al.
Publicado: (2018)

Splenomegaly in myelofibrosis—new options for therapy and the therapeutic potential of Janus kinase 2 inhibitors
por: Randhawa, Jasleen, et al.
Publicado: (2012)

Ruxolitinib rechallenge in combination with hydroxyurea is effective in reverting cachexia and reducing blood transfusion demand and splenomegaly symptoms in a patient with primary myelofibrosis
por: Cerchione, Claudio, et al.
Publicado: (2017)

Circulating Calreticulin Is Increased in Myelofibrosis: Correlation with Interleukin-6 Plasma Levels, Bone Marrow Fibrosis, and Splenomegaly
por: Sollazzo, Daria, et al.
Publicado: (2016)

Elevated plasma EDA fibronectin in primary myelofibrosis is determined by high allele burden of JAK2V617F mutation and strongly predicts splenomegaly progression
por: Malara, Alessandro, et al.
Publicado: (2022)

Ultrasound imaging of splenomegaly as a proxy to monitor colon tumor development in Apc (min716/+) mice
por: Hodgson, Andrea, et al.
Publicado: (2016)

P1007: SPLENOMEGALY DEVELOPMENT PRECEDES THE PROGRESS OF HEMATOPOIETIC STEM CELLS MIGRATION TO SPLEEN IN MURINE MYELOFIBROSIS MODELS
por: Kawamura, Toshikuni, et al.
Publicado: (2023)

P1041: IMPACT OF FEDRATINIB ON SPLEEN VOLUME AND MYELOFIBROSIS SYMPTOMS IN PATIENTS WITH SUBSTANTIAL SPLENOMEGALY: POST HOC ANALYSES FROM THE JAKARTA AND JAKARTA2 TRIALS
por: Kiladjian, J.-J., et al.
Publicado: (2022)

The role of growth differentiation factor 15 in the pathogenesis of primary myelofibrosis
por: Uchiyama, Tatsuki, et al.
Publicado: (2015)

Dwarfism associated with wandering splenomegaly
por: Petroianu, Andy, et al.
Publicado: (2022)

Treatment Patterns, Health Care Resource Utilization, and Cost in Patients with Myelofibrosis in the United States
por: Copher, Ronda, et al.
Publicado: (2022)

Splenectomy for Splenomegaly
por: Nixon, J. A.
Publicado: (1913)

Splenomegaly in Britain
por: McNee, J. W.
Publicado: (1929)

Splenomegaly in Britain
por: McNee, J. W.
Publicado: (1929)

Lymphadenopathy and Splenomegaly
por: Lanzkowsky, Philip
Publicado: (2011)

Splenectomy for Splenomegaly
Publicado: (1914)

Wandering splenomegaly reduction after splenopexy
por: Petroianu, Andy, et al.
Publicado: (2021)

Abstract 7 Reduced Intensity Conditioning Umbilical Cord Blood Transplantation in Combination with Splenic Irradiation in a Patient with Secondary Myelofibrosis and Massive Splenomegaly
por: Kaabneh, Basil, et al.
Publicado: (2022)

Diffuse Angiokeratoma: Report of Two Cases with Diffuse Skin Changes, One with Neurological Symptoms and Splenomegaly
por: Brown, Alexander, et al.
Publicado: (1952)

Treatment patterns, adverse events, and economic burden in a privately insured population of patients with chronic lymphocytic leukemia in the United States
por: Kabadi, Shaum M., et al.
Publicado: (2019)

Assessment of sites of marrow and extramedullary hematopoiesis by hybrid imaging in primary myelofibrosis patients
por: Ojeda‐Uribe, Mario, et al.
Publicado: (2016)

Adding hydroxyurea in combination with ruxolitinib improves clinical responses in hyperproliferative forms of myelofibrosis
por: Pugliese, Novella, et al.
Publicado: (2019)

An Uncommon Cause of Splenomegaly
por: Dey, Biswajit, et al.
Publicado: (2016)

Splenectomy for Tropical Splenomegaly
Publicado: (1935)

Splenectomy for Tropical Splenomegaly
por: Palit, A. N.
Publicado: (1935)

Surgery for massive splenomegaly
por: Lemaire, J., et al.
Publicado: (2017)

Notes on Splenomegaly and Splenectomy
por: McKendrick, J. Souttar
Publicado: (1922)

Management of massive splenomegaly
por: Hudson, Victoria E., et al.
Publicado: (2021)

Splenomegaly in Children and Adolescents
por: Suttorp, Meinolf, et al.
Publicado: (2021)

Safety and efficacy of combination therapy of interferon‐α2 and ruxolitinib in polycythemia vera and myelofibrosis
por: Mikkelsen, Stine Ulrik, et al.
Publicado: (2018)

Management of cytopenias in patients with myelofibrosis treated with ruxolitinib and effect of dose modifications on efficacy outcomes
por: Verstovsek, Srdan, et al.
Publicado: (2013)

Elevated RIPK3 correlates with disease burden in myelofibrosis
por: Dill, Veronika, et al.
Publicado: (2022)

Patterns of hydroxyurea use and clinical outcomes among patients with polycythemia vera in real-world clinical practice: a chart review
por: Parasuraman, Shreekant, et al.
Publicado: (2016)

Second primary malignancies in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 2233 patients
por: Mora, Barbara, et al.
Publicado: (2019)

Pancreatic cancer symptom trajectories from Danish registry data and free text in electronic health records
por: Hjaltelin, Jessica Xin, et al.
Publicado: (2023)

Fever, splenomegaly and lymphopenia in sarcoidosis
por: Ravaglia, Claudia, et al.
Publicado: (2013)

Pedunculine. (For Treatment of Bengal Splenomegaly)
por: Sanyal, Subodh Chandra
Publicado: (1946)

Cannot write session to /tmp/vufind_sessions/sess_es4fonuvl12umc91jrpntue15f